US 9481692
Heterocyclic modulators of HIF activity for treatment of disease
granted A61KA61K31/4245A61K31/427
Quick answer
US patent 9481692 (Heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4245, A61K31/427, A61K31/437, A61K31/4439